FDA looks to make drugs risks clearer for patients
June 22, 2011Medical Communications FDA, advertising
Potential side effects from medicines need to be presented more clearly on prescription drug advertising so patients can understand the …
European approval for BMS kidney transplant drug Nulojix
June 22, 2011Sales and Marketing BMS, EMA, Nulojix, transplant
European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …
FDA rejects Novartis’ Ilaris for gouty arthritis
June 22, 2011Research and Development Ilaris, Novartis, gouty arthritis
An FDA advisory panel has voted against backing Novartis’ Ilaris for gouty arthritis because of safety concerns. Ilaris (canakinumab) is …
Careers in next generation contract partnering
June 22, 2011Business Services, Manufacturing and Production, Research and Development contract manufacturing, contract research, cros
Over the past few years, a significant shift has occurred in the depth and type of relations that the pharma …
Working Life: Neurotune’s chief executive
June 22, 2011Business Services, Research and Development Working Life, recruitment
Bruno Oesch, chief executive of Swiss biopharmaceutical company Neurotune, talks to Pharmafocus about being at the interface of science and …
David Kane to lead CCC’s Biosector 2
June 22, 2011Medical Communications appointment, medical communications
Chandler Chicco Companies (CCC) has appointed David Kane as managing director of its healthcare PR agency Biosector 2. He moves …
Health research charities hit back at animal rights campaign
June 21, 2011Medical Communications Animal testing, Animal tests, Cancer Research UK, animal activists
Four of the UK’s leading health research charities have hit back after being accused of funding “horrific animal experiments” by …
FDA approves Pfizer pain drug Oxecta
June 21, 2011Sales and Marketing FDA, Oxecta, Pfizer, chronic pain
The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …
NICE gains expanded role alongside value-based pricing
June 21, 2011Sales and Marketing NHS reforms, NICE, value-based pricing
NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …
NICE backs Celgene’s thalidomide and Janssen’s Velcade
June 21, 2011Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma
Celgene’s thalidomide and Janssen-Cilag’s Velcade have been given the thumbs up by NICE as a treatment for a cancer that …
Pfizer project is quality-by-design milestone for FDA and EMA
June 21, 2011Manufacturing and Production EMA, FDA, Quality by Design, pharma manufacturing news
A pilot project set up earlier this year to encourage the adoption of quality-by-design in pharmaceutical manufacturing has passed its …
Novartis breaks ground on $500m Russian facility
June 21, 2011Manufacturing and Production Novartis, Russia, pharma manufacturing news
Novartis has started construction of its new pharmaceutical manufacturing plant in St. Petersburg, Russia.The company has broken ground on the …
Dr Reddy’s API plant in Mexico under FDA scrutiny
June 21, 2011Manufacturing and Production APIs, Dr Reddy's, FDA, GMP violations, pharma manufacturing news
Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …
Interlace Global Group appoints ten new staff
June 21, 2011Medical Communications apppointment, medical communications
Interlace Global Group has expanded the client services and editorial teams at its twin companies Wells Healthcare and Interlace Global …
Smelly Risperdal adds to J&J’s recall tally
June 20, 2011Manufacturing and Production John Lechleiter, pharma manufacturing news, recalls
Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …
NICE guideline helping to cut referrals
June 20, 2011GSK, NICE, bph
A NICE guideline on treating lower urinary tract symptoms (LUTS) in men is helping to cut referrals to urologists, thereby …
Mid-stage trial boost for Roche skin cancer drug vismodegib
June 20, 2011Research and Development Cancer, Roche, skin cancer, vismodegib
Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …
GlaxoSmithKline expands Canadian manufacturing plant
June 20, 2011Manufacturing and Production GSK, pharma manufacturing news
GlaxoSmithKline has set aside almost £19 million ($31 million) to expand a manufacturing facility in Ontario, Canada, creating 70 additional …
NICE reprieved by government U-turn
June 20, 2011Sales and Marketing Health and Social Care Bill, NICE, value-based pricing
The government has performed an unexpected U-turn by allowing NICE to retain its powers to decide which new drugs the …
Double Helix appoints Sarah Frere-Cook and Ginevra Drinka
June 20, 2011Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing
Double Helix has boosted its London-based strategic market research team with two new appointments. Sarah Frere-Cook joins as a research …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
